Sepiapterin Reductase Inhibitors For The Treatment of Pain
申请人:Blagg Julian
公开号:US20120322800A1
公开(公告)日:2012-12-20
Disclosed herein are small molecule heterocyclic inhibitors of sepiapterin reductase (SPR), and prodrugs and pharmaceutically acceptable salts thereof. The Also featured are pharmaceutical compositions of the compounds and uses of these compounds for the treatment or prevention of pain (e.g., inflammatory pain, nociceptive pain, functional pain, and neuropathic pain).
SEPIAPTERIN REDUCTASE INHIBITORS FOR THE TREATMENT OF PAIN
申请人:Children's Medical Center Corporation
公开号:US20160031812A1
公开(公告)日:2016-02-04
Disclosed herein are small molecule heterocyclic inhibitors of sepiapterin reductase (SPR), and prodrugs and pharmaceutically acceptable salts thereof. The Also featured are pharmaceutical compositions of the compounds and uses of these compounds for the treatment or prevention of pain (e.g., inflammatory pain, nociceptive pain, functional pain, and neuropathic pain).
US9169234B2
申请人:——
公开号:US9169234B2
公开(公告)日:2015-10-27
[EN] SEPIAPTERIN REDUCTASE INHIBITORS FOR THE TREATMENT OF PAIN<br/>[FR] INHIBITEURS DE SÉPIAPTÉRINE RÉDUCTASE POUR LE TRAITEMENT DE LA DOULEUR
申请人:HERCULES TECHNOLOGY MAN CO V INC
公开号:WO2011047156A1
公开(公告)日:2011-04-21
Disclosed herein are small molecule heterocyclic inhibitors of sepiapterin reductase (SPR), and prodrugs and pharmaceutically acceptable salts thereof. The Also featured are pharmaceutical compositions of the compounds and uses of these compounds for the treatment or prevention of pain (e.g., inflammatory pain, nociceptive pain, functional pain, and neuropathic pain).